‹ All Posts
Vineet Chawla

26th Feb 2025 · SEBI-Registered Analyst

RSI Enters Oversold Zone: Buying Opportunity Ahead?

SUNPHARMA
The Relative Strength Index (RSI) has entered the oversold zone, indicating that the stock may be due for a bounce. An RSI reading below 30 suggests that the stock has been oversold and may be poised for a rebound. Trading Implications - Potential buying opportunity for traders - Increased likelihood of short-term bounce - Traders should watch for signs of bullish reversal Caution: Oversold conditions can persist, and traders should be prepared for further downside before a potential bounce.

#WatchOutFor#TechnicalViews#EquityResearch
Image 26-02-25 at 9.45 AM.jpeg
147 likes·76 comments